-
Even with an annual Pap smear test and the new vaccination for young women, cervical cancer can’t be totally prevented. But there are some things you can do to reduce your risk of developing cancer of the cervix.
-
Vaginal cancer is a relatively rare disorder, comprising about 2% to 3% of all gynecologic cancers. Approximately 2,400 women are diagnosed each year with vaginal cancer in the United States.
-
The chance of getting ovarian cancer increases as a woman gets older. Ovarian cancer occurs in women over the age of 50 and the highest risk is in women over 60.
-
Uterine cancer is the most common of all cancers in the female reproductive system. It can either form in the inner lining of the uterus or the outer layer of muscle tissue.
-
Thought to be caused by a problem with the genetic information transmitted between an egg and sperm, molar pregnancy can develop during the first trimester of pregnancy.
Testimonials
-
When Jan Holsclaw found out she had ovarian cancer, she was referred to Dr. Bigsby at Florida Hospital Cancer Institute for surgery and treatment. With reassuring words and...
-
TV Personality Jan C. Garavaglia, M.D., (aka "Dr. G") is the chief medical examiner for the District Nine (Orange-Osceola) Medical Examiner's Office in Florida. When she... -
Bonnie has helped to raise millions of dollars for ovarian cancer research taking place at National Cancer Institute (NCI), Department of Defense (DOD), Centers for Disease...
Ovarian Cancer Research
Ovarian Cancer Research
Researchers around the world and at the Florida Hospital Cancer Institute are working on a number of fronts to prevent, treat and cure ovarian cancer, hopefully within our lifetime.
Following are some of the most recent developments in cervical cancer research:
Inhibitors
Another promising treatment is the use of PARP inhibitors that act on a protein known as PARP. When another protein called BRCA malfunctions, PARP steps in and takes over so the cancer can survive. By inhibiting PARP, you can hopefully also inhibit ovarian cancer.
Gene Profiling
Another study is looking at analyzing the patterns of gene activity to predict an ovarian tumor’s response to different therapies. Where doctors used to think all ovarian tumors were alike, subtypes are being discovered and the effectiveness of treatment may vary by subtype.
Clinical trials are underway on a number of fronts. Currently, the National Cancer Institute lists nearly 400 trials underway for the most common form of ovarian cancer alone and the Gynecologic Oncology Center offers patients more clinical trial options than any other healthcare facility in the region. Ask your Gynecologic Oncology Center doctor about clinical trials being conducted at the center.
For a complete list, click here.
Hedge Hog Pathway Inhibitors: Need info